Biorasis

Mansfield, United Kingdom Founded: 2007 • Age: 19 yrs
Continuous glucose monitoring is facilitated by a sensor platform.
Request Access

About Biorasis

Biorasis is a company based in Mansfield (United Kingdom) founded in 2007.. Biorasis has raised $3 million across 10 funding rounds from investors including HHS, MassChallenge and Helmsley Charitable Trust. Biorasis offers products and services including GLUCOWIZZARD and Metabolic Monitoring Platform. Biorasis operates in a competitive market with competitors including Dexcom, Livongo, Bigfoot Biomedical, Senseonics and One Drop, among others.

  • Headquarter Mansfield, United Kingdom
  • Sectors
    Healthcare
    Technology
  • Phone
    *********
  • Website
    *********
  • Legal Name Biorasis, Inc
Operational Areas
Healthcare → Healthcare Products & Supplies
Technology → Extended, Virtual & Augmented Reality
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $3 M (USD)

    in 10 rounds

  • Latest Funding Round
    $3 M (USD), Series A

    Nov 14, 2018

  • Investors
    HHS

    & 3 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Biorasis

Biorasis offers a comprehensive portfolio of products and services, including GLUCOWIZZARD and Metabolic Monitoring Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Miniaturized device for reading and transmitting glucose levels wirelessly.

Platform for real-time continuous monitoring of metabolic indicators.

Funding Insights of Biorasis

Biorasis has successfully raised a total of $3M across 10 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 10
  • Last Round Series A — $3.0M
  • First Round

    (28 Sep 2009)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2018 Amount Series A - Biorasis Valuation

investors

May, 2016 Amount Grant - Biorasis Valuation

investors

Oct, 2015 Amount Grant - Biorasis Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Biorasis

Biorasis has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, MassChallenge and Helmsley Charitable Trust. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early-stage entrepreneurs are accelerated through MassChallenge's program.
Founded Year Domain Location
A charitable trust focused on healthcare and research funding.
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Biorasis

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Biorasis

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Biorasis Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Biorasis

Biorasis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, Bigfoot Biomedical, Senseonics and One Drop, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Wearable glucose monitoring patches are provided for real-time data tracking.
domain founded_year HQ Location
Provider of smart devices for diabetes management for patients and doctors
domain founded_year HQ Location
Developer of a closed-loop automated insulin delivery system
domain founded_year HQ Location
Implantable continuous glucose monitoring systems are provided for diabetes management.
domain founded_year HQ Location
Provider of workforce healthcare solutions
domain founded_year HQ Location
Gamified apps for diabetes management and therapy are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Biorasis

Frequently Asked Questions about Biorasis

When was Biorasis founded?

Biorasis was founded in 2007 and raised its 1st funding round 2 years after it was founded.

Where is Biorasis located?

Biorasis is headquartered in Mansfield, United Kingdom. It is registered at Mansfield, England, United Kingdom.

Is Biorasis a funded company?

Biorasis is a funded company, having raised a total of $3M across 10 funding rounds to date. The company's 1st funding round was a Grant of $100K, raised on Sep 28, 2009.

What does Biorasis do?

Biorasis was founded in 2007 and is based in Mansfield, United Kingdom. Operations focus on the medical device sector, where a sensor platform for continuous glucose monitoring is developed. Glucose levels are read by a tiny sensor and transmitted to personal digital accessories like smartphones or computers. An implantable multi-sensor platform is also offered for real-time, continuous monitoring of vital signs.

Who are the top competitors of Biorasis?

Biorasis's top competitors include Dexcom, Senseonics and Bigfoot Biomedical.

What products or services does Biorasis offer?

Biorasis offers GLUCOWIZZARD and Metabolic Monitoring Platform.

Who are Biorasis's investors?

Biorasis has 4 investors. Key investors include HHS, MassChallenge, Helmsley Charitable Trust, and National Science Foundation.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available